Ovarian Reserve Testing and Elective Egg Freezing

ONLINEENDURING MATERIALAMA

Add to Calendar Ovarian Reserve Testing and Elective Egg Freezing 6/8/2022 12:00:00 AM 6/8/2023 12:00:00 PM Asia/Riyadh For More Details: https://wcmq.cloud-cme.com/course/courseoverview?P=0&EID=2278 Online false MM/DD/YYYY


Date & Location
Wednesday, June 8, 2022, 12:00 AM - Thursday, June 8, 2023, 12:00 PM, Online, Doha, Qatar

Overview

This online lecture provides physicians and other healthcare practitioners updates on current issues related to healthcare. The lecture will be maximum of one hour in length, followed by post test. Participants will have the opportunity to learn about ovarian reserve testing and elective egg freezing.

  • Release Date: June 8, 2022
  • End Date: June 8, 2023

Target Audience
Specialties - Allied Health Professionals, Dentists, Nurses, Pharmacists, Physicians, Researchers, Students


Objectives
  1. 1- Demonstrate the impact of age on fertility decline
  2. 2- Appraise the various methods of ovarian reserve testing
  3. 3- Assess the indications of elective egg freezing
  4. 4- Illustrate the counseling of women undergoing ovarian reserve testing

Registration
FREE of charge

Accreditation

The Ministry of Public Health's Department of Healthcare Professions (DHP) considers Asynchronous activities under Category 2 as self-directed learning.  

 
Weill Cornell Medicine-Qatar is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Weill Cornell Medicine-Qatar designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Relationships/Content Validity

It is the policy of Weill Cornell Medicine-Qatar to the Ministry of Public Health's Department of Healthcare Professions (DHP) and Accreditation Council for Continuing Medical Education (ACCME) Criteria, Policies, and Standards for Commercial Support and content validation in order to ensure fair balance, independence, objectivity, and scientific rigor in all its sponsored programs. All faculty participating in sponsored programs are expected to disclose relevant financial relationships pertaining to their contribution to the activity, and any discussions of off-label or investigational uses of approved commercial products or devices, or of any products or devices not yet approved in the United States and elsewhere. WCM-Q CME/CPD activities are intended to be evidence-based and free of commercial bias. 

Bibliography:

1. Ethics Committee of the American Society for Reproductive Medicine. Planned oocyte cryopreservation for women seeking to preserve future reproductive potential: an Ethics Committee opinion. Fertil Steril 2018;110(6):1022-1028. 

2. Dewailly D, Andersen CY, Balen A, Broekmans F, Dilaver N, Fanchin R, Griesinger G, Kelsey TW, La Marca A, Lambalk C, Mason H, Nelson SM, Visser JA, Wallace WH, Anderson RA. The physiology and clinical utility of anti-Mullerian hormone in women. Hum Reprod Update 2014;20(3):370-85.

3. La Marca A, Sunkara SK. Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice. Hum Reprod Update 2014;20(1):124-40.

4. Doyle JO, Richter KS, Lim J, Stillman RJ, Graham JR, Tucker MJ. Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities for fertility preservation according to number of cryopreserved oocytes and age at retrieval. Fertil Steril 2016;105(2):459-66.e2.